Oral controlled release formulation design and drug delivery : theory to practice

Preface. Contributors. 1 Introduction and Overview of Oral Controlled Release Formulation Design (Hong Wen and Kinam Park). 2 Evolution of Oral Controlled Release Dosage Forms (Ping I. Lee and Jian-Xin Li). 3 Biopharmaceutic Consideration and Assessment for Oral Controlled Release (CR) Formulations (Hua Zhang and Jean M. Surian). 4 Preformulation Consideration for Drugs in Oral CR Formulation (Manching Sherry Ku). 5 Polymers in Oral Modified Release Systems (Jiasheng Tu, Yan Shen, Ravichandran Mahalingam, Bhaskara Jasti, and Xiaoling Li). 6 Oral Extended Release Hydrophilic Matrices: Formulation and Design (Xiaoguang Wen, Ali Nokhodchi, and Ali Rajabi-Siahboomi). 7 Coating Systems for Oral Controlled Release Formulations (Linda A. Felton). 8 Fluid Bed Coating and Granulation for CR Delivery (Yue Teng and Zhihui Qiu). 9 Controlled Release using Bilayer Osmotic Tablet Technology: Reducing Theory to Practice (Sheri L Shamblin). 10 Fast Disintegrating Tablets (Seong Hoon Jeong, Jaehwi Lee, and Jong Soo Woo). 11 Buccal Drug Delivery Systems (John D. Smart and Gemma Keegan). 12 Oral Targeted Drug Delivery Systems: Gastric Retention Devices (Hamid Omidian and Kinam Park). 13 Oral Targeted Drug Delivery Systems: Enteric Coating (Wendy Dulin). 14 Orally Administered Drug Delivery Systems to the Colon (Mirela Nadler Milabuer, Yossi Kam and Abraham Rubinstein). 15 Dissolution Testing: In Vitro Characterization of Oral Controlled Release Dosage Forms (Michele Xuemei Guo). 16 Challenges and New Technologies of Oral Controlled Release (Xiaoming Chen, Hong Wen and Kinam Park). 17 Oral Controlled Drug Delivery: Quality By Design (QbD) Approach to Drug Development (Shailesh Singh, Thirunellai G. Venkateshwaran and Stephen P. Simmons). 18 Oral Controlled Release-Based Products for Life Cycle Management (Nipun Davar and Sangita Ghosh). 19 Generic Oral Controlled Release Product Development: Formulation and Process Considerations (Salah U. Ahmed and Venkatesh Naini). 20 The Science and Regulatory Perspectives of Emerging Controlled Release Dosage Forms (Rakhi B. Shah and Mansoor A. Khan). Index.

[1]  M. Cramer,et al.  Translating Safety, Efficacy and Compliance into Economic Value for Controlled Release Dosage Forms , 1994, PharmacoEconomics.

[2]  J. Blondeau.  Current Issues in the Management of Urinary Tract Infections , 2012, Drugs.

[3]  Karen L. Goa,et al.  Once-Weekly Fluoxetine , 2012, Drugs.

[4]  ジェイ． チェン ミング,et al.  Controlled release oral dosage form and use of poorly soluble drugs , 2011 .

[5]  K. Pielichowski,et al.  Preparation and thermal characterization of poly(ethylene oxide)/griseofulvin solid dispersions for biomedical applications , 2009 .

[6]  A. Basit,et al.  Gut instincts: explorations in intestinal physiology and drug delivery. , 2008, International journal of pharmaceutics.

[7]  M. Mateescu,et al.  Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  N. Venkatesan,et al.  Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine. , 2008, Current drug delivery.

[9]  L. S. Taylor,et al.  Spontaneous crystallinity loss of drugs in the disordered regions of poly(ethylene oxide) in the presence of water. , 2008, Journal of pharmaceutical sciences.

[10]  Wei He,et al.  Biphasic drug release: permeability and swelling of pectin/ethylcellulose films, and in vitro and in vivo correlation of film-coated pellets in dogs. , 2008, Chemical & pharmaceutical bulletin.

[11]  Da-Wei Chen,et al.  Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres. , 2008, Chemical & pharmaceutical bulletin.

[12]  Hardik K. Shah,et al.  Enteric Coating for Colonic Delivery , 2008 .

[13]  Kinam Park,et al.  Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. , 2008, International journal of pharmaceutics.

[14]  Long-xiao Liu,et al.  Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. , 2008, International journal of pharmaceutics.

[15]  Christopher J H Porter,et al.  Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.

[16]  Jenn‐Shing Chen,et al.  Characterization of hydrogels prepared from copolymerization of the different degrees of methacrylate-grafted chondroitin sulfate macromers and acrylic acid. , 2008, Journal of biomedical materials research. Part A.

[17]  K. Goracinova,et al.  Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  Ali Nokhodchi,et al.  Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  H. Onishi,et al.  Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  C. Sharma,et al.  Tricalcium phosphate delayed release formulation for oral delivery of insulin: a proof-of-concept study. , 2008, Journal of pharmaceutical sciences.

[21]  J. Siepmann,et al.  Polymer blends for controlled release coatings. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Kinam Park,et al.  Superporous IPN hydrogels having enhanced mechanical properties , 2003, AAPS PharmSciTech.

[23]  A. Nokhodchi,et al.  Factors affecting the release of nifedipine from a swellable elementary osmotic pump. , 2008, Drug delivery.

[24]  A. Bajaj,et al.  Development and evaluation of push-pull based osmotic delivery system for pramipexole. , 2008, PDA journal of pharmaceutical science and technology.

[25]  XueTao Jiang,et al.  Design and evaluation of a dry coated drug delivery system with floating-pulsatile release. , 2008, Journal of pharmaceutical sciences.

[26]  R. Manzo,et al.  Double-layered mucoadhesive tablets containing nystatin , 2008, AAPS PharmSciTech.

[27]  L. Kleinberg,et al.  Implications on Emergence of Antimicrobial Resistance as a Critical Aspect in the Design of Oral Sustained Release Delivery Systems of Antimicrobials , 2008, Pharmaceutical Research.

[28]  J. Chaumeil,et al.  Increased Intestinal Delivery of Viable Saccharomyces boulardii by Encapsulation in Microspheres , 2008, Pharmaceutical Research.

[29]  G. Sedek,et al.  Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. , 2007, International journal of clinical pharmacology and therapeutics.

[30]  Y. Murata,et al.  The drug release profile from calcium-induced alginate gel beads coated with an alginate hydrolysate. , 2007, Molecules.

[31]  A. Domb,et al.  Mucoadhesive tablet releasing iodine for treating oral infections. , 2007, Journal of pharmaceutical sciences.

[32]  G. Kaur,et al.  Recent approaches for colon drug delivery. , 2007, Recent patents on drug delivery & formulation.

[33]  H. Stevens,et al.  In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  V. Kadam,et al.  Ion Exchange Resins: A Novel Way to Solve Formulation Problems , 2007 .

[35]  A. Hsu,et al.  The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease. , 2007, Current clinical pharmacology.

[36]  A. Ghaffari,et al.  Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  J. Smart,et al.  An in vitro assessment of bioadhesive zinc/carbomer complexes for antimicrobial therapy within the oral cavity. , 2007, International journal of pharmaceutics.

[38]  G. Remuzzi,et al.  Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination , 2007, Vascular health and risk management.

[39]  Beom-Jin Lee,et al.  Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings. , 2007, International journal of pharmaceutics.

[40]  S. Bajpai,et al.  Ion Exchange Resins in Drug Delivery , 2007 .

[41]  T. Pal,et al.  In‐vitro and in‐vivo correlation for two gliclazide extended‐release tablets , 2007, The Journal of pharmacy and pharmacology.

[42]  F. Podczeck,et al.  Gastrointestinal transit of model mini‐tablet controlled release oral dosage forms in fasted human volunteers , 2007, The Journal of pharmacy and pharmacology.

[43]  G. Pitarresi,et al.  Photocrosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[44]  J. Sugg,et al.  Metoprolol succinate extended release/hydrochlorothiazide combination tablets , 2007, Vascular health and risk management.

[45]  B. Mccarberg.  Tramadol extended-release in the management of chronic pain , 2007, Therapeutics and clinical risk management.

[46]  Hua Zheng,et al.  Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. , 2007, International journal of pharmaceutics.

[47]  M. Alonso,et al.  Development of chitosan sponges for buccal administration of insulin , 2007 .

[48]  F. Veiga,et al.  Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. , 2007, Nanomedicine.

[49]  Hong Liu,et al.  Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation. , 2007, International journal of pharmaceutics.

[50]  Kinam Park,et al.  Recent developments in superporous hydrogels , 2007, The Journal of pharmacy and pharmacology.

[51]  Dissolution: Fundamentals of In Vitro Release and the Biopharmaceutics Classification System , 2007 .

[52]  D. Young.  In Vitro–In Vivo Correlation for Modified Release Parenteral Drug Delivery Systems , 2007 .

[53]  V. Stella,et al.  Evaluation of various properties of alternative salt forms of sulfobutylether-β-cyclodextrin, (SBE)7M-β-CD , 2007 .

[54]  Lichen Yin,et al.  Superporous hydrogels containing poly(acrylic acid-co-acrylamide)/O-carboxymethyl chitosan interpenetrating polymer networks. , 2007, Biomaterials.

[55]  Brahma N. Singh.  Modified-release solid formulations for colonic delivery. , 2007, Recent patents on drug delivery & formulation.

[56]  P. McCarron,et al.  Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. , 2007, Journal of photochemistry and photobiology. B, Biology.

[57]  Sanjay K. Jain,et al.  Potential of calcium pectinate beads for target specific drug release to colon , 2007, Journal of drug targeting.

[58]  A. Nokhodchi,et al.  Propranolol Hydrochloride Osmotic Capsule with Controlled Onset of Release , 2007, Drug delivery.

[59]  W. Pan,et al.  Studies on Bi-Layer Osmotic Pump Tablets of Water-Insoluble Allopurinol with Large Dose: In Vitro and In Vivo , 2007, Drug development and industrial pharmacy.

[60]  Kenneth C. Waterman.  A Critical Review of Gastric Retentive Controlled Drug Delivery , 2007, Pharmaceutical development and technology.

[61]  Mayur M. Patel,et al.  Therapeutic opportunities in colon-specific drug-delivery systems. , 2007, Critical reviews in therapeutic drug carrier systems.

[62]  M. Gümüşderelioğlu,et al.  Release characteristics of salmon calcitonin from dextran hydrogels for colon-specific delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[63]  C. Peterson,et al.  Pharmacokinetic Modeling of Absorption Behavior of 9-Aminocamptothecin (9-AC) Released from Colon-specific HPMA Copolymer–9-AC Conjugate in Rats , 2007, Pharmaceutical Research.

[64]  D. Laight,et al.  Orally administered, colon-specific mucoadhesive azopolymer particles for the treatment of inflammatory bowel disease: An in vivo study. , 2006, Journal of biomedical materials research. Part A.

[65]  J. Karkalas,et al.  Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis. , 2006, Carbohydrate research.

[66]  Jie Sun,et al.  Colon-specific delivery tablets of sodium 4-aminosalicylic acid. , 2006, Yao xue xue bao = Acta pharmaceutica Sinica.

[67]  Suneel K. Gupta,et al.  Clinical spectrum of the osmotic-controlled release oral delivery system (OROS*), an advanced oral delivery form , 2006, Current medical research and opinion.

[68]  T. Vandamme,et al.  Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[69]  K. Morris,et al.  Raman spectroscopy for tablet coating thickness quantification and coating characterization in the presence of strong fluorescent interference. , 2006, Journal of pharmaceutical and biomedical analysis.

[70]  K. Leong,et al.  Chitosan nanoparticles for oral drug and gene delivery , 2006, International journal of nanomedicine.

[71]  S. Kondo,et al.  Preparation of floating drug delivery system by plasma technique. , 2006, Chemical & pharmaceutical bulletin.

[72]  A. Basit,et al.  A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. , 2006, International journal of pharmaceutics.

[73]  Kinam Park,et al.  Preparation of fast-dissolving tablets based on mannose , 2006 .

[74]  S. Chandran,et al.  Multiparticulate formulation approach to colon specific drug delivery: current perspectives. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[75]  V. Pillay,et al.  Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. , 2005, International journal of pharmaceutics.

[76]  Kinam Park,et al.  Fast-melting tablets based on highly plastic granules. , 2005, Journal of Controlled Release.

[77]  S. Simon.  Opioids and treatment of chronic pain: understanding pain patterns and the role for rapid-onset opioids. , 2005, MedGenMed : Medscape general medicine.

[78]  T. Sonobe,et al.  Formulation study and drug release mechanism of a new theophylline sustained-release preparation. , 2005, International journal of pharmaceutics.

[79]  N. Hosten,et al.  Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging , 2005, Alimentary pharmacology & therapeutics.

[80]  N. Shah,et al.  Scale-Up of Extrusion and Spheronization , 2005 .

[81]  C. Korstanje.  The Improved Cardiovascular Safety of Omnic (Tamsulosin) Oral Controlled Absorption System (OCAS , 2005 .

[82]  J. Remon,et al.  Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers. , 2005, International journal of pharmaceutics.

[83]  G. Granneman,et al.  Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC). , 2005, Journal of pharmaceutical sciences.

[84]  M. Sangalli,et al.  Oral pulsatile drug delivery systems , 2005, Expert opinion on drug delivery.

[85]  A. Thombre.  Assessment of the feasibility of oral controlled release in an exploratory development setting. , 2005, Drug discovery today.

[86]  Edward R Grant,et al.  Raman spectroscopic measurement of tablet-to-tablet coating variability. , 2005, Journal of pharmaceutical and biomedical analysis.

[87]  J. Staniforth,et al.  TIMERx®: novel polysaccharide composites for controlled/programmed release of drugs in the gastrointestinal tract , 2005, Expert opinion on drug delivery.

[88]  T. Abribat,et al.  The rise and rise of drug delivery , 2005, Nature Reviews Drug Discovery.

[89]  레너 이츠하크이.,et al.  Delayed release formulations of 6-mercaptopurine , 2005 .

[90]  デイビッド エンスコア,et al.  Polymeric drug delivery system for hydrophobic drugs , 2005 .

[91]  P. Sriamornsak,et al.  Emulsion gel beads of calcium pectinate capable of floating on the gastric fluid: effect of some additives, hardening agent or coating on release behavior of metronidazole. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[92]  S. Davis,et al.  Formulation strategies for absorption windows. , 2005, Drug discovery today.

[93]  D. Friend.  New oral delivery systems for treatment of inflammatory bowel disease. , 2005, Advanced drug delivery reviews.

[94]  B. A. Johnson,et al.  Use of the Antioxidant BHT in Asymmetric Membrane Tablet Coatings to Stabilize the Core to the Acid Catalyzed Peroxide Oxidation of a Thioether Drug , 2005, Pharmaceutical development and technology.

[95]  J. Sousa,et al.  Role of Cellulose Ether Polymers on Ibuprofen Release from Matrix Tablets , 2005, Drug development and industrial pharmacy.

[96]  M. A. Holgado,et al.  Elaboration and “In Vitro” Characterization of 5-ASA Beads , 2005, Drug development and industrial pharmacy.

[97]  A. Berchielli,et al.  A Thermodynamic Model for Organic and Aqueous Tablet Film Coating , 2005, Pharmaceutical development and technology.

[98]  G. Amidon,et al.  Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects , 1987, Digestive Diseases and Sciences.

[99]  R. Kotsilkova,et al.  Rheological characteristics and diffusion processes in mixed cellulose hydrogel matrices , 2005 .

[100]  H. Fessi,et al.  Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.

[101]  Xiaoling Li,et al.  Advances in buccal drug delivery. , 2005, Critical reviews in therapeutic drug carrier systems.

[102]  H. Okamoto,et al.  Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[103]  A. Rawat,et al.  Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. , 2004, International journal of pharmaceutics.

[104]  Carlo Rossi,et al.  Development of mucoadhesive patches for buccal administration of ibuprofen. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[105]  B. Youan,et al.  Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[106]  J. Xiong,et al.  Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide). , 2004, International journal of pharmaceutics.

[107]  S. Unal,et al.  Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[108]  Shajahan Abdul,et al.  A flexible technology for modified release of drugs: multi layered tablets. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[109]  Sara Eyal,et al.  Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. , 2004, International journal of pharmaceutics.

[110]  J. Tsibouklis,et al.  In situ evaluation of drug-loaded microspheres on a mucosal surface under dynamic test conditions. , 2004, International journal of pharmaceutics.

[111]  S. Wartewig,et al.  Polyethylene oxides: protection potential against polymorphic transitions of drugs? , 2004 .

[112]  J. Smart.  Lectin-mediated drug delivery in the oral cavity. , 2004, Advanced drug delivery reviews.

[113]  Kinam Park,et al.  Semi-interpenetrating Polymer Network Superporous Hydrogels Based on Poly(3-Sulfopropyl Acrylate, Potassium Salt) and Poly(Vinyl Alcohol): Synthesis and Characterization , 2004 .

[114]  D. Law,et al.  Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. , 2004, Journal of pharmaceutical sciences.

[115]  M. Sentjurc,et al.  In vivo study of different ointments for drug delivery into oral mucosa by EPR oximetry. , 2004, International journal of pharmaceutics.

[116]  J. Remon,et al.  Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[117]  R. Turnock,et al.  Colonic transit time--what is normal? , 2004, Journal of pediatric surgery.

[118]  S C Sutton,et al.  Osmotic drug delivery using swellable-core technology. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[119]  R. Fassihi,et al.  Gastroretentive Delivery Systems: A Mini Review , 2004, Drug development and industrial pharmacy.

[120]  P. Sheskey,et al.  Preliminary Report of the Discovery of a New Pharmaceutical Granulation Process Using Foamed Aqueous Binders , 2004, Drug development and industrial pharmacy.

[121]  Jinhe Li,et al.  Effect of Colonic Lactulose Availability on the Timing of Drug Release Onset in Vivo from a Unique Colon-Specific Drug Delivery System (CODES™) , 2003, Pharmaceutical Research.

[122]  A. Hoffman,et al.  Novel Gastroretentive Dosage Forms: Evaluation of Gastroretentivity and Its Effect on Riboflavin Absorption in Dogs , 2002, Pharmaceutical Research.

[123]  Bruno C. Hancock,et al.  What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.

[124]  Lawrence X. Yu.  An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.

[125]  B. Yagen,et al.  Low Swelling, Crosslinked Guar and Its Potential Use as Colon-Specific Drug Carrier , 1998, Pharmaceutical Research.

[126]  R. Busson,et al.  Inulin Hydrogels as Carriers for Colonic Drug Targeting: I. Synthesis and Characterization of Methacrylated Inulin and Hydrogel Formation , 1997, Pharmaceutical Research.

[127]  J. Fix.  Oral Controlled Release Technology for Peptides: Status and Future Prospects , 1996, Pharmaceutical Research.

[128]  D. Parkins,et al.  Pectin/Ethylcellulose Film Coating Formulations for Colonic Drug Delivery , 1996, Pharmaceutical Research.

[129]  E. Kalso,et al.  Controlled Release of Lidocaine from Injectable Gels and Efficacy in Rat Sciatic Nerve Block , 1995, Pharmaceutical Research.

[130]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[131]  C. Samyn,et al.  In Vivo Evaluation of a Colon-Specific Drug Delivery System: An Absorption Study of Theophylline from Capsules Coated with Azo Polymers in Rats , 1995, Pharmaceutical Research.

[132]  Ping I. Lee,et al.  Probing the Mechanisms of Drug Release from Hydroxypropylmethyl Cellulose Matrices , 1994, Pharmaceutical Research.

[133]  Kevin C. Johnson,et al.  Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.

[134]  Xin Xu,et al.  Programmable Drug Delivery from an Erodible Association Polymer System , 1993, Pharmaceutical Research.

[135]  Jindřich Kopeček,et al.  Hydrogels for Site-Specific Drug Delivery to the Colon: In Vitro and in Vivo Degradation , 1992, Pharmaceutical Research.

[136]  I. Wilding,et al.  Gastrointestinal Transit and Systemic Absorption of Captopril from a Pulsed-Release Formulation , 1992, Pharmaceutical Research.

[137]  Colin R. Gardner,et al.  Controlled Gastric Emptying. II. In Vitro Erosion and Gastric Residence Times of an Erodible Device in Beagle Dogs , 1989, Pharmaceutical Research.

[138]  C. Gardner,et al.  Controlled Gastric Emptying. 1. Effects of Physical Properties on Gastric Residence Times of Nondisintegrating Geometric Shapes in Beagle Dogs , 1988, Pharmaceutical Research.

[139]  Joseph R. Robinson,et al.  Mechanisms of Mucoadhesion of Poly(acrylic Acid) Hydrogels , 1987, Pharmaceutical Research.

[140]  A. Shirwaikar,et al.  Sustained release bi-layered tablets of diltiazem hydrochloride using insoluble matrix system , 2004 .

[141]  J. E. Carter,et al.  In Vitro and in Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms , 2004, Pharmaceutical Research.

[142]  Rafiqul Gani,et al.  Computer-aided and predictive models for design of controlled release of pesticides , 2004 .

[143]  R. Talbert,et al.  Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[144]  Duane D. Miller,et al.  Emerging trends in oral delivery of peptide and protein drugs. , 2003, Critical reviews in therapeutic drug carrier systems.

[145]  N. Nafee,et al.  Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. , 2003, International journal of pharmaceutics.

[146]  J. I. Yoon,et al.  Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel , 2003, Archives of pharmacal research.

[147]  J. Tsibouklis,et al.  Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. , 2003, Journal of pharmaceutical sciences.

[148]  David S. Jones,et al.  Rheological and mucoadhesive characterization of polymeric systems composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone), designed as platforms for topical drug delivery. , 2003, Journal of pharmaceutical sciences.

[149]  P. Vavia,et al.  Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[150]  K. Zhu,et al.  Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS). , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[151]  Y. Seta,et al.  Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. , 2003, International journal of pharmaceutics.

[152]  S. Rossi,et al.  Buccal Delivery of Acyclovir from Films Based on Chitosan and Polyacrylic Acid , 2003, Pharmaceutical development and technology.

[153]  Clive G. Wilson,et al.  Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[154]  Hitoshi Kawai,et al.  Studies on lactulose formulations for colon-specific drug delivery. , 2002, International journal of pharmaceutics.

[155]  M. Másson,et al.  Mucoadhesive Sustained Drug Delivery System Based on Cationic Polymer and Anionic Cyclodextrin/Triclosan Complex , 2002 .

[156]  J. Staniforth,et al.  TIMERx Oral Controlled-Release Drug Delivery System , 2002 .

[157]  Y Zhou,et al.  Theoretical analyses of dispersed-drug release from planar matrices with a boundary layer in a finite medium. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[158]  J. Remon,et al.  Plaque-inhibiting effect of bioadhesive mucosal tablets containing chlorhexidine in a 4-day plaque regrowth model , 2002, Clinical Oral Investigations.

[159]  Yan Zhang,et al.  Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting. , 2002, World journal of gastroenterology.

[160]  M. Bouchoucha,et al.  Importance of colonic transit evaluation in the management of fecal incontinence , 2002, International Journal of Colorectal Disease.

[161]  J. Pieper.  Understanding niacin formulations. , 2002, American Journal of Managed Care.

[162]  모로다니엘지.,et al.  Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds , 2002 .

[163]  Kamlesh Mohanlal Dudhara,et al.  Gastric retention system with a controlled drug release , 2002 .

[164]  B. Aungst,et al.  Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes. , 2002, Journal of pharmaceutical sciences.

[165]  J. Ali,et al.  Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation. , 2002, International journal of pharmaceutics.

[166]  T. Nagai,et al.  Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. , 2002, International journal of pharmaceutics.

[167]  D. Rogers,et al.  A quantitative evaluation of radiolabelled lectin retention on oral mucosa in vitro and in vivo. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[168]  Y. Seta,et al.  Comparison of the mechanical destructive force in the small intestine of dog and human. , 2002, International journal of pharmaceutics.

[169]  Clive G. Wilson,et al.  The release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[170]  Clive G. Wilson,et al.  Evaluation of Pulsincap to provide regional delivery of dofetilide to the human GI tract. , 2002, International journal of pharmaceutics.

[171]  C. Novák,et al.  Effect of Molecular Mass on the Melting Temperature, Enthalpy and Entropy of Hydroxy-Terminated PEO , 2002 .

[172]  P. Giunchedi,et al.  Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[173]  S. Garg,et al.  Formulation aspects in the development of osmotically controlled oral drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[174]  H. Tønnesen,et al.  Alginate in Drug Delivery Systems , 2002, Drug development and industrial pharmacy.

[175]  M. Michel.  A Benefit-Risk Assessment of Extended-Release Oxybutynin , 2002, Drug safety.

[176]  E. Klein.  The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam. , 2002, The Journal of clinical psychiatry.

[177]  A. Sandler.  Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings , 2001 .

[178]  G・P・迪特马,et al.  Pharmaceutical dosage form with multiple coatings , 2001 .

[179]  J D Smart,et al.  A direct-staining method to evaluate the mucoadhesion of polymers from aqueous dispersion. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[180]  Y. Seta,et al.  Evaluation of the mechanical destructive force in the stomach of dog. , 2001, International journal of pharmaceutics.

[181]  플래쉬너-바락모쉬,et al.  Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates , 2001 .

[182]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[183]  Y. Maitani,et al.  In vitro permeation studies of triamcinolone acetonide mouthwashes. , 2001, International journal of pharmaceutics.

[184]  S. Şenel,et al.  Delivery of bioactive peptides and proteins across oral (buccal) mucosa. , 2001, Current pharmaceutical biotechnology.

[185]  J. Dressman,et al.  A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[186]  H. Park,et al.  Effect of compression on fast swelling of poly(acrylamide-co-acrylic acid) superporous hydrogels. , 2001, Journal of biomedical materials research.

[187]  루이-헬름제니,et al.  Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms , 2001 .

[188]  C. Samyn,et al.  Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting. , 2001, International journal of pharmaceutics.

[189]  A. Perkins,et al.  Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfate. , 2001, International journal of pharmaceutics.

[190]  Yun-jin Jung,et al.  Synthesis and Properties of Dextran–Nalidixic Acid Ester as a Colon-Specific Prodrug of Nalidixic Acid , 2001, Drug development and industrial pharmacy.

[191]  P. Shang,et al.  Effects of Polyethylene Glycol on Morphology, Thermomechanical Properties, and Water Vapor Permeability of Cellulose Acetate-Free Films , 2001 .

[192]  Sanjay Garg,et al.  Current Status of Drug Delivery Technologies and Future Directions , 2001 .

[193]  G. Meron.  The development of the swallowable video capsule (M2A). , 2000, Gastrointestinal endoscopy.

[194]  J. Urquhart,et al.  Controlled drug delivery: therapeutic and pharmacological aspects , 2000 .

[195]  W. Fiers,et al.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.

[196]  S. Friedman,et al.  In vitro studies and modeling of a controlled-release device for root canal therapy. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[197]  G. Khang,et al.  Monolithic osmotic tablet system for nifedipine delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[198]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[199]  F. André,et al.  controlled release dosage forms. , 2000 .

[200]  A. Thombre.  Feasibility Assessment and Rapid Development of Oral Controlled Release Prototypes , 2000 .

[201]  S. I. Kim,et al.  Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: its properties, degradation behavior, and utilization for drug formulation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[202]  Joshua R. Smith,et al.  An atomic force microscopy investigation of bioadhesive polymer adsorption onto human buccal cells. , 2000, International journal of pharmaceutics.

[203]  J. Fix,et al.  In Vitro Determination of Disintegration Time of Quick-Dissolve Tablets Using a New Method , 2000, Pharmaceutical development and technology.

[204]  S. Garg,et al.  Osmotically Controlled Oral Drug Delivery** , 2000, Drug development and industrial pharmacy.

[205]  J. Smart,et al.  An in vitro mucosal model predictive of bioadhesive agents in the oral cavity. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[206]  R. M. Arthur,et al.  A SUSTAINED RELEASE FORMULATION OF ISOSORBIDE‐5‐MONONITRATE WITH A RAPID ONSET OF ACTION , 1999, International journal of clinical practice.

[207]  V. Stella,et al.  Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[208]  M. Z. Khan,et al.  A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[209]  J A Dowell,et al.  Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. , 1999, Journal of pharmaceutical sciences.

[210]  G. Hsiue,et al.  Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system. , 1999, Journal of biomaterials science. Polymer edition.

[211]  A. Markham,et al.  Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease. , 1999, Drugs.

[212]  K. Kolter,et al.  Lauroyldextran and crosslinked galactomannan as coating materials for site-specific drug delivery to the colon. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[213]  D. Mason,et al.  Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (Carbatrol and Tegretol-XR). , 1998, Journal of pharmaceutical sciences.

[214]  P. Wertz,et al.  Drug delivery via the buccal mucosa , 1998 .

[215]  Lawrence X. Yu,et al.  Characterization of small intestinal transit time distribution in humans , 1998 .

[216]  フィッシャー ヴィルフリート,et al.  Controlled release pharmaceutical preparation having a kind of ace inhibitors , 1998 .

[217]  F. Hirayama,et al.  Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration. , 1998, Journal of pharmaceutical sciences.

[218]  J. Tsibouklis,et al.  Azocrosslinked poly(acrylic acid) for colonic delivery and adhesion specificity: in vitro degradation and preliminary ex vivo bioadhesion studies. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[219]  H. Brøndsted,et al.  Crosslinked dextran--a new capsule material for colon targeting of drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[220]  Richard Bowtell,et al.  Magnetic resonance imaging of controlled release pharmaceutical dosage forms , 1998 .

[221]  M. Alonso,et al.  Design of microencapsulated chitosan microspheres for colonic drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[222]  S. Satyanarayana,et al.  In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[223]  Kinam Park,et al.  Gastric retentive drug-delivery systems. , 1998, Critical reviews in therapeutic drug carrier systems.

[224]  L. Lesko,et al.  The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules. , 1998, Pharmaceutical development and technology.

[225]  J. Urquhart.  Can drug delivery systems deliver value in the new pharmaceutical marketplace? , 2003, British journal of clinical pharmacology.

[226]  ウォッシンク，サンドラ，イー．,et al.  Soluble form osmotic dose delivery system , 1997 .

[227]  제니 루이-헬름.  Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter , 1997 .

[228]  Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation. , 1997, International journal of clinical pharmacology and therapeutics.

[229]  G. Venkatesh,et al.  Compaction simulator study of a novel triple-layer tablet matrix for industrial tableting , 1997 .

[230]  J. Fell,et al.  Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release , 1997 .

[231]  D. Parkins,et al.  Studies on Amidated Pectins as Potential Carriers in Colonic Drug Delivery , 1997, The Journal of pharmacy and pharmacology.

[232]  I. Wilding,et al.  Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation , 1997, Alimentary pharmacology & therapeutics.

[233]  T. Maruyama,et al.  Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. , 1996, Journal of pharmaceutical sciences.

[234]  M. Khan,et al.  Atenolol Gastrointestinal Therapeutic System. I. Screening of Formulation Variables , 1997 .

[235]  S. Han,et al.  Thermal/oxidative degradation and stabilization of polyethylene glycol , 1997 .

[236]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[237]  F. Veiga,et al.  Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices , 1997 .

[238]  D. Piscitelli,et al.  Setting dissolution specifications for modified-release dosage forms. , 1997, Advances in experimental medicine and biology.

[239]  R. Foster,et al.  The Nifedipine Gastrointestinal Therapeutic System (GITS) , 2012, Clinical pharmacokinetics.

[240]  L. Yang,et al.  Characterization of compressibility and compactibility of poly(ethylene oxide) polymers for modified release application by compaction simulator. , 1996, Journal of pharmaceutical sciences.

[241]  Lawrence X. Yu,et al.  Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .

[242]  P. R. Nixon,et al.  Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. , 1996, Journal of Pharmacy and Science.

[243]  J. Ahlskog.  Treatment of early Parkinson's disease: are complicated strategies justified? , 1996, Mayo Clinic proceedings.

[244]  V. Alvisi,et al.  Bioavailability of a controlled release formulation of ursodeoxycholic acid in man. , 1996, Drugs under experimental and clinical research.

[245]  Richard W. Baker,et al.  Osmotic drug delivery : a review of the patent literature , 1995 .

[246]  Thau-Ming Cham,et al.  Compression behavior and tensile strength of heat-treated polyethylene glycols , 1995 .

[247]  M. Fukui,et al.  System for colon specific release of a drug. , 1995 .

[248]  Jm Newton,et al.  Comparative gastrointestinal transit of pellet systems of varying density , 1995 .

[249]  Alfonso R. Gennaro,et al.  Remington:the science and practice of pharmacy , 1995 .

[250]  K. P. Rao,et al.  Azo polymeric hydrogels for colon targeted drug delivery. , 1995, Biomaterials.

[251]  María Victoria Margarit,et al.  Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000 , 1994 .

[252]  K. Yukimatsu,et al.  Development of a Trans-Mucosal Controlled-Release Device for Systemic Delivery of Antianginal Drugs Pharmacokinetics and Pharmacodynamics , 1994 .

[253]  J. Robinson,et al.  Oral cavity as a site for bioadhesive drug delivery , 1994 .

[254]  Jian-Hwa Guo.  Effects of Plasticizers on Water Permeation and Mechanical Properties of Cellulose Acetate: Antiplasticization in Slightly Plasticized Polymer Film , 1993 .

[255]  D. Fox,et al.  Osmotic systems for colon-targeted drug delivery , 1993 .

[256]  J. Hutton,et al.  Long‐acting carbidopa‐levodopa in the management of moderate and advanced Parkinson's disease , 1992, Neurology.

[257]  M. Kelbert,et al.  Valuation of a Cellulose Acetate (CA) latex as coating material for controlled release products , 1992 .

[258]  A. Thombre,et al.  A delivery device containing a poorly water-soluble drug in a hydrophobic medium: ruminal delivery application , 1992 .

[259]  J. L. Gómez-Amoza,et al.  Influence of technological variables on release of drugs from hydrophilic matrices , 1992 .

[260]  P. Giunchedi,et al.  Ibuprofen delayed release dosage forms : a proposal for the preparation of an in vitro/in vivo pulsatile system , 1992 .

[261]  M. Bialer.  Pharmacokinetic Evaluation of Sustained Release Formulations of Antiepileptic Drugs , 1992, Clinical pharmacokinetics.

[262]  E. Michelson.  Calcium antagonists in cardiology: Update on sustained‐release drug delivery systems , 1991, Clinical cardiology.

[263]  D. Coomans,et al.  Development and Testing of Bioadhesive, Fluoride‐containing Slow‐release Tablets for Oral Use , 1991, The Journal of pharmacy and pharmacology.

[264]  W. Ritschel.  Targeting in the gastrointestinal tract: new approaches. , 1991, Methods and findings in experimental and clinical pharmacology.

[265]  B. Norlander,et al.  Pharmacokinetics of a 5‐aminosalicylic acid enteric‐coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteers , 1990, Alimentary pharmacology & therapeutics.

[266]  J. Newton,et al.  The influence of density on the gastrointestinal transit of pellets , 1990, The Journal of pharmacy and pharmacology.

[267]  J. Cummings,et al.  Non-invasive method for delivery of tracer substances or small quantities of other materials to the colon. , 1990, Gut.

[268]  F. Lapeyre,et al.  Oral sustained release dosage forms comparison between matrices and reservoir devices , 1989 .

[269]  A La Manna,et al.  Swelling-activated drug delivery systems. , 1988, Biomaterials.

[270]  I. Bjarnason,et al.  Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis , 1988, Gut.

[271]  S. Janicki,et al.  In vitro study of gastrointestinal diffusion system using disopyramide phosphate. , 1987, Die Pharmazie.

[272]  Nikolaos A. Peppas,et al.  Prediction of polymer dissolution in swellable controlled-release systems☆ , 1987 .

[273]  J. Robinson,et al.  Some biological issues in oral, controlled drug delivery , 1987 .

[274]  Richard W. Baker,et al.  Controlled Release of Biologically Active Agents , 1987 .

[275]  R. Gurny,et al.  Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate , 1986 .

[276]  Ping I. Lee.  Initial concentration distribution as a mechanism for regulating drug release from diffusion controlled and surface erosion controlled matrix systems , 1986 .

[277]  R. Gordon,et al.  Evaluation of polyvinyl acetate phthalate as an enteric coating material , 1985 .

[278]  K. Himmelstein,et al.  The controlled porosity osmotic pump , 1985 .

[279]  J. Moppert,et al.  Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report. , 1985, British journal of clinical pharmacology.

[280]  J. V. Swintosky.  Personal Adventures in Biopharmaceutical Research during the 1953–1984 Years , 1985, Drug intelligence & clinical pharmacy.

[281]  W. Good,et al.  Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration. , 1985, British Journal of Clinical Pharmacology.

[282]  A. Takahashi,et al.  Dissolution mechanism for hydroxypropyl methylcellulose acetate succinate used in the enteric coating of tablets. , 1985 .

[283]  C. Swartz,et al.  The treatment of tricyclic antidepressant overdose with repeated charcoal. , 1984, Journal of clinical psychopharmacology.

[284]  P. I. Lee,et al.  Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels. , 1984, Journal of pharmaceutical sciences.

[285]  Clive G. Wilson,et al.  A comparative study of the gastrointestinal transit of a pellet and tablet formulation , 1984 .

[286]  G. Peck,et al.  Aspartame-Mannitol Resolidified Fused Mixture: Characterization Studies by Differential Scanning Calorimetry, Thermomicroscopy, Photomicrography and X-Ray Diffractometry , 1984 .

[287]  D. Greenblatt,et al.  Long v short half-life benzodiazepines in the elderly???kinetics and clinical effects of diazepam and oxazepam , 1983 .

[288]  H. Neu,et al.  Digoxin-inactivating bacteria: identification in human gut flora. , 1983, Science.

[289]  D. Greenblatt,et al.  Absolute Bioavailability of Oral and Intramuscular Diazepam: Effects of Age and Sex , 1983, Anesthesia and analgesia.

[290]  J. Stafford,et al.  Enteric Film Coating Using Completely Aqueous Dissolved Hydroxypropyl Methyl Cellulose Phthalate Spray Solutions , 1982 .

[291]  Ghislain Devroede,et al.  Segmental colonic transit time , 1981, Diseases of the colon and rectum.

[292]  V. P. Butler,et al.  Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. , 1981, The New England journal of medicine.

[293]  L. Amsel,et al.  Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs. , 1981, Journal of pharmaceutical sciences.

[294]  Ping I. Lee.  Diffusional release of a solute from a polymeric matrix — approximate analytical solutions , 1980 .

[295]  R. Miller,et al.  Reduction of Ischemic Injury by Sublingual Nitroglycerin in Patients with Acute Myocardial Infarction , 1976, Circulation.

[296]  F Theeuwes,et al.  Elementary osmotic pump. , 1975, Journal of pharmaceutical sciences.

[297]  P. Elworthy,et al.  Solubilization of griseofulvin by nonionic surfactants , 1968 .

[298]  M. Kochhar,et al.  Cellulose acetate succinate as an enteric coating for some compressed tablets. , 1962, Journal of pharmaceutical sciences.

[299]  J. Cooper,et al.  Absorption, testing, and clinical evaluation of oral prolonged-action drugs. , 1961, Journal of pharmaceutical sciences.

[300]  J. Cooper,et al.  Oral Prolonged Action Medicaments: Their Pharmaceutical Control and Therapeutic Aspects , 1959, The Journal of pharmacy and pharmacology.

[301]  C. Dragstedt.  Oral medication with preparations for prolonged action. , 1958, Journal of the American Medical Association.

[302]  S. Rose,et al.  A continuous long-term injector. , 1955, The Australian journal of experimental biology and medical science.

[303]  C. O. Lee,et al.  History, literature, and theory of enteric coatings * , 1945 .